STMN2 and Parkinson disease: Upregulation of these PD GWAS genes suggested a compensatory mechanism in response to Stmn2 deficiency, while SYT4-mediated somatodendritic release of DA was a key mechanism for the autoregulatory control of DA release in the brain53.